Philip L Felgner Selected Research

Philip L Felgner Research Topics

Disease

58	Infections 01/2022 - 01/2005
40	Malaria 09/2021 - 07/2006
12	COVID-19 01/2022 - 01/2020
9	Communicable Diseases (Infectious Diseases) 01/2021 - 02/2010
7	Schistosomiasis (Bilharziasis) 11/2021 - 01/2010
6	Vaccinia 08/2014 - 01/2005
5	Reinfection 01/2021 - 03/2014
5	Persistent Infection 01/2016 - 08/2010
5	Melioidosis 07/2011 - 01/2009
4	Human Influenza (Influenza) 01/2022 - 12/2018
4	Leptospirosis 01/2021 - 01/2013
4	Q Fever (Fever, Q) 01/2021 - 12/2008
4	Typhoid Fever (Typhoid) 01/2017 - 01/2013
4	Brucellosis (Malta Fever) 01/2014 - 05/2010
3	Pneumonia (Pneumonitis) 01/2022 - 01/2011
3	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2018 - 07/2006
3	Tularemia 01/2016 - 06/2007
3	Toxoplasmosis 05/2015 - 02/2007
3	Tuberculosis (Tuberculoses) 09/2012 - 08/2010
2	Schistosomiasis haematobia (Schistosomiasis haematobium) 11/2021 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2020
2	Bacteremia 01/2021 - 03/2012
2	Neoplasms (Cancer) 01/2021 - 01/2015
2	Fever (Fevers) 03/2016 - 03/2014
2	Bites and Stings (Sting) 03/2016 - 12/2013
2	Pemphigus (Pemphigus Vulgaris) 01/2013 - 02/2011
2	Neglected Diseases 01/2013 - 01/2009
1	Bacillary Dysentery (Shigellosis) 01/2021
1	Poliomyelitis (Polio) 01/2021
1	Papilloma (Papillomatosis) 01/2021
1	Chronic Traumatic Encephalopathy 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Tauopathies 01/2020
1	Virus Diseases (Viral Diseases) 12/2018
1	Cerebral Malaria 01/2018
1	Inflammation (Inflammations) 01/2017
1	Cholera 01/2017
1	Schistosomiasis japonica 01/2016

Drug/Important Bio-Agent (IBA)

73	AntigensIBA 11/2021 - 01/2005
65	Proteins (Proteins, Gene)FDA Link 09/2021 - 09/2005
42	VaccinesIBA 01/2022 - 01/2005
37	AntibodiesIBA 11/2021 - 10/2007
19	Immunoglobulin G (IgG)IBA 11/2021 - 07/2011
19	ProteomeIBA 01/2021 - 01/2005
11	Subunit VaccinesIBA 01/2021 - 01/2009
9	Biomarkers (Surrogate Marker)IBA 11/2021 - 08/2010
9	Immunoglobulin M (IgM)IBA 01/2018 - 07/2011
8	EpitopesIBA 03/2021 - 06/2008
6	Immunoglobulin A (IgA)IBA 09/2021 - 01/2016
5	Surface Antigens (Surface Antigen)IBA 01/2021 - 11/2011
5	Peptides (Polypeptides)IBA 01/2020 - 07/2011
4	Malaria VaccinesIBA 10/2017 - 01/2015
3	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 09/2021 - 12/2015
3	EnzymesIBA 01/2021 - 01/2014
3	Hemolysin Proteins (Hemolysins)IBA 06/2017 - 03/2014
3	Immunodominant EpitopesIBA 08/2014 - 05/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 02/2007
2	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 01/2019
2	Neutralizing AntibodiesIBA 01/2022 - 09/2021
2	Praziquantel (Biltricide)FDA Link 01/2021 - 01/2015
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
2	ImmunosorbentsIBA 01/2021 - 03/2014
2	NucleoproteinsIBA 01/2021 - 05/2020
2	Chloroquine (Aralen)FDA LinkGeneric 01/2019 - 12/2013
2	Collodion (Nitrocellulose)IBA 01/2019 - 12/2008
2	LipopolysaccharidesIBA 06/2017 - 01/2016
2	Polysaccharides (Glycans)IBA 01/2017 - 01/2009
2	CytokinesIBA 10/2015 - 07/2011
2	Recombinant ProteinsIBA 05/2015 - 01/2012
2	Interferon-gamma (Interferon, gamma)IBA 01/2014 - 07/2011
2	AutoantibodiesIBA 01/2013 - 02/2011
2	Immune Sera (Antisera)IBA 03/2012 - 01/2010
2	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 05/2007 - 09/2005
1	amotosalenIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Messenger RNA (mRNA)IBA 11/2021
1	Immunologic Factors (Immunomodulators)IBA 09/2021
1	Combined VaccinesIBA 01/2021
1	FCPAIBA 01/2021
1	AC133 AntigenIBA 01/2021
1	Disinfectants (Biocides)IBA 01/2021
1	Single-Chain AntibodiesIBA 01/2020
1	Tissue ExtractsIBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 08/2019
1	Indicators and Reagents (Reagents)IBA 08/2019
1	Neuraminidase (Sialidase)IBA 01/2019
1	FlagellinIBA 01/2018
1	Type V Secretion SystemsIBA 01/2018
1	pertactin FDA Link 01/2018
1	endoxo-delta(4)-tetrahydrophthalic acidIBA 01/2018
1	2- (N- phenethyl- N- propyl)amino- 5- hydroxytetralinIBA 01/2017
1	AllergensIBA 01/2016
1	Antimalarials (Antimalarial Agents)IBA 11/2015
1	Immunoglobulins (Immunoglobulin)IBA 09/2015
1	Inosine Diphosphate (IDP)IBA 07/2015

Therapy/Procedure

5	Therapeutics 09/2021 - 01/2011
3	Immunotherapy 01/2022 - 10/2007
2	Mass Drug Administration 01/2017 - 03/2014
1	Chemoprevention 01/2019